Recent events
Recent events tied to this brand in public sources.
Back to profile6 entries
2022
Brii Biosciences and Sinopharm form strategic commercialization partnership
Brii Biosciences announced that its controlled company, 腾盛华创, had entered a strategic partnership with Sinopharm to advance the China commercialization of the BRII-196/BRII-198 combination therapy, including drug reserves, distribution channels, and regional access.
2021
Medical specialists warn against Sinopharm vaccine use in Sri Lanka
The Association of Medical Specialists warned against using the Sinopharm vaccine in Sri Lanka, citing an expert panel's conclusion that the available data were insufficient to determine its safety, efficacy and immunogenicity.
2021
Sinopharm Holdings appoints Yu Qingming as board chairman
On January 14, Sinopharm Holdings announced that its board had elected Yu Qingming as board chairman, as well as chairman of the board’s strategy and investment committee and nomination committee.
2020
Summer Atlantic Capital signs strategic partnership with Sinopharm
Summer Atlantic Capital announced that it had signed a strategic partnership agreement with Sinopharm to introduce pharmaceutical and medical device technologies to mainland China. The agreement adds Sinopharm to Summer Atlantic Capital's network for evaluating medical technologies.
2020
Fosun Pharma and Sinopharm sign vaccine logistics partnership
Fosun Pharma and Sinopharm Holding signed a strategic logistics cooperation agreement for the BioNTech mRNA vaccine, including plans to jointly establish a vaccine cold-chain system and improve storage, transport and distribution services.
2020
Sinopharm wins Best Southbound Stock Connect Company award
Sinopharm Holdings received the Best Southbound Stock Connect Company award at the fourth Golden Hong Kong Stocks annual selection.